[국가임상시험지원재단] 해외 임상시험 정보 데이터(Global Data) 보고서

Global Data Intelligence Center
구분	보고서 (영문)	업로드 날짜
제약/바이오/임상시험	Keytruda Wins Second Place in the Race to Approval for Neo-adjuvant NSCLC	10-20-2023
	Manufacturing Issues Delay Lebrikizumab’s Entry to the Atopic Dermatitis Market	10-23-2023
	Pear Therapeutics: A Lesson for Future DTx Developers	10-23-2023
	Opdivo’s Additional FDA Nod Continues the Battle of Immune Checkpoint Inhibitors	10-23-2023
	AnapstysBio’s Imsidolimab Phase III Trial’s Promising Results Can Bring it Closer to Marketing Approval	10-25-2023
	Venture Financing for Targeted Protein Degraders Soars in 2022	10-27-2023
	North America Leads Dose Response Trials	10-30-2023
	Upcoming Breast Cancer Trials in China	10-31-2023
	Tibsovo Unlocks a New Era for Rare Blood Cancers Called Myelodysplastic Syndromes	10-31-2023
	US Meningococcal Vaccines Market to Begin to Shift Towards Pentavalent Vaccines	11-02-2023
질환별	Neuronopathic Therapies Are a Serious Unmet Need in the Treatment of Gaucher Disease	10-18-2023
	Red Meat Consumption Linked to Elevated Type 2 Diabetes Rate	10-23-2023
	Antimicrobial Resistance Threatens to Set Modern Medicine Back Decades	10-24-2023
	Finding the Crohn’s Disease Leader Is Underway with the Anti-Interleukin 23s	10-25-2023
	Myasthenia Gravis: Opportunity Assessment and Forecast	10-31-2023
컨퍼런스/ 심포지엄/학회	ESMO 2023: Mirati’s Krazati and Immuno-oncology Combination to Shape KRAS-mutated First-Line NSCLC Landscape	10-23-2023
	ESMO 2023: MSD’s Welireg Sets the Stage for HIF-2alpha Inhibitors in Clear Cell RCC Despite Unclear OS	10-23-2023
	ESMO 2023: Astellas’s Padcev Combo Disrupts Urothelial Cancer Landscape with EV-302 Results	11-02-2023
	Highlights from the ESMO 2023 Congress: Antibody-Drug Conjugates and Bispecific T-cell Engagers	11-02-2023